Subject: Nasdaq Stocks End Mixed Amid Worry Over Earnings of Technology Concerns 
Date: Published: 7/18/91 (31 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    OTC Focus:
    Nasdaq Stocks End Mixed Amid Worry
    Over Earnings of Technology Concerns
    ----
    By Dave Pettit
    Staff Reporter of The Wall Street Journal

    NEW YORK -- Over-the-counter stocks closed mixed as
 investors continued to sort through an onslaught of earnings
 news.
    Concerns about disappointing earnings battered technology
 stocks for a second consecutive day.  Even companies posting
 profits within the range of analyst expectations saw their
 shares marked down.
    Newport Pharmaceuticals lost 1/2 to 4 after its
 Scandinavian licensee withdrew an application for Newport's
 drug, Isoprinosine, under a Common Market coordinated
 approval procedure.  The licensee, Leo Pharmaceutical
 Products, was seeking approval of the drug for use in the
 early stages of AIDS.  Separately, Newport posted
 second-quarter net of two cents a share, compared with a
 year-ago loss of 18 cents.

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]